Papenfuss Donnalee Kathleen
Papenfuss Donnalee Kathleen, ESC, reported a transaction classified as exercise at FASTENAL CO involving 1364.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 13, 2026
- Filing date
- Aug 17, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
FAST price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0002043506-26-000005 Employee Stock Option (Right to Buy)
- Transaction date
- Aug 13, 2026 Filed Aug 17, 2026, 03:19 PM · 4d delay
- Shares
- 1,364 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 0 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
EVP-Strategy and Communication
- F1
Shares attributed to reporting person's account within issuer's 401(K) Plan and includes an additional 345 shares acquired in the account since the last report on 6/9/2025.
- F2
The option will vest and become exercisable over a period of eight years, with 25% of the option vesting and becoming exercisable two years after the relevant vesting period, and the remainder vesting…
- F3
The option was previously reported in a Form 3 filing on 11/6/2024 and the amounts reported on this Form 4 are adjusted to reflect a 2-for-1 stock split on May 21, 2025.
- F4
The option will vest and become exercisable over a period of five years, with 40% of the option vesting and becoming exercisable two years following the date of grant, and the remainder vesting and be…
0 other transactions
0 recent txs